Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Sep 2;16(9):e0257107. doi: 10.1371/journal.pone.0257107

Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan

Satoshi Sunohara 1,#, Toshiaki Asakura 1,#, Takashi Kimura 2,*, Shun Ozawa 1, Satoshi Oshima 1, Daigo Yamauchi 1, Akiko Tamakoshi 2
Editor: Martial L Ndeffo Mbah3
PMCID: PMC8412346  PMID: 34473809

Abstract

Due to COVID-19, many countries including Japan have implemented a suspension of economic activities for infection control. It has contributed to reduce the transmission of COVID-19 but caused severe economic losses. Today, several promising vaccines have been developed and are already being distributed in some countries. Therefore, we evaluated various vaccine and intensive countermeasure strategies with constraint of economic loss using SEIR model to obtain knowledge of how to balance economy with infection control in Japan. Our main results were that the vaccination strategy that prioritized younger generation was better in terms of deaths when a linear relationship between lockdown intensity and acceptable economic loss was assumed. On the other hand, when a non-linearity relationship was introduced, implying that the strong lockdown with small economic loss was possible, the old first strategies were best in the settings of small basic reproduction number. These results indicated a high potential of remote work when prioritizing vaccination for the old generation. When focusing on only the old first strategies as the Japanese government has decided to do, the strategy vaccinating the young next to the old was superior to the others when a non-linear relationship was assumed due to sufficient reduction of contact with small economic loss.

Introduction

At the end of 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus began in Wuhan City (Hubei Province, China) [1, 2]. Over one hundred million people worldwide have been infected with COVID-19 since it was declared to be a pandemic by the World Health Organization on March 11th, 2020. As of April 1st, 2021, the death toll was over 2.8 million worldwide and over 9,000 in Japan [3].

Due to this pandemic, many countries have implemented a suspension of economic activities (usually referred to as a lockdown) with restrictions on movement [4, 5]. It has been observed that the implementation of the lockdown reduces contact rate and thus transmission of SARS-CoV-2 [69]. On the other hand, lockdowns stopped economic activity and caused severe economic losses [1012]. In Japan, no enforceable policy of movement restrictions was implemented, but the government declared a state of emergency, not a strict lockdown, to control the spread of SARS-CoV-2. This declaration allowed prefectural governors to take measures such as restricting the operation of public facilities, including schools, and reducing the hours of operation of restaurants [13, 14]. This measure resulted in economic losses like lockdown policies in other countries. In the situation of pandemic of COVID-19, the world’s GDP and Japan’s GDP were estimated to have shrunk by 5.2% [15] and by 4.8% [16] in 2020, respectively.

Today, unlike the situation at the time of the emergence of SARS-CoV-2, several promising vaccines have been developed and are already being distributed in some countries [17]. As of the 15th of June, 20.8% of the world’s population has been vaccinated at least once, especially in many developed countries, where more than 40% of the population has already been vaccinated. However, in low-income countries, only 0.8% of the population has been vaccinated at least once, and vaccination in low-income countries is still an issue. As a consequence, some developed countries like Israel and UK have confirmed a decrease in the number of newly reported case of infection [3]. In Japan, vaccination for healthcare workers has begun in March 2021, and vaccination for the general elderly population has been implemented from April 12th, 2021. However, until herd immunity is established by vaccinating a certain percentage of the population, it is necessary to continue controlling contacts as a preventive measure against infection. This will require knowledge of how to balance economy with infection control under progression of vaccination.

Therefore, we evaluated various vaccine and intensive countermeasure strategies with constraint of predefined amount of economical loss using SEIR model.

Materials and methods

Simulation scenarios

We assumed that vaccine was started to be distributed at the start of the simulation and that all individuals received vaccination within one year at a constant rate. We used a lockdown as one of intensive countermeasures. Acceptable economic loss was predefined and intensity, length and start timing of the lockdown were optimized to minimize the cumulative number of deaths at the end of the simulation, comparing with different vaccination strategies. It is noted that the lockdown used in this study is defined as countermeasures not only reducing transmissibility but also causing economical damage. Our usage of the lockdown includes containment and closure indicators of OxCGRT indicators [13], for example workplace closing, cancel public events, restrictions on gathering size and stay-at-home requirements. On the other hand, neither countermeasures without economical damage (ex. mask wearing, improving hand hygiene and public information campaign) nor economical supports are included in our usage of the lockdown.

We divided population into young (15–49 years old), middle (50–64 years old) and old (more than 64-year-old) populations and ignored child age group (0–14 years old) since age was critical factor for contact rates and mortality, and also for simplicity of simulation settings [18]. 10 vaccine allocation strategies were compared in the present study. One scenario was equal allocation for all age groups. 6 scenarios were precise prioritization for 3 generations. For example, old generations were targeted at first. If all old individuals received vaccination, the next target was middle age group. After that, young generations received vaccination. The other 3 scenarios were partial prioritization strategies. One age group was targeted at first and the rest of vaccines were allocated equally to the other two age groups.

Regarding lockdown strategies, it was assumed that the lockdown was performed only once during each simulation since there was a small chance of resurgence of COVID-19 at the latter phase of the simulation due to vaccination. To balance economy with infection control, we varied three parameters related with the lockdown: start timing, ts, intensity for age group j, Lj, and length, TL, of the lockdown. In our main analyses, the lockdown was equally imposed to all generations so that Lj = L for any age group. Simulations with different intensities of the lockdown between generations were performed as a sensitivity analysis.

Loss of total production value due to the lockdown was defined as economic loss, E, expressed as a proportion to the non-lockdown situation and calculated as

E=TL365θ(jwjNjLjjwjNj)1+ϕ, (1)

where wj and Nj was an average production value and the number of populations for age group j, respectively. θ was defined as lockdown efficacy and we assumed 25% of population would not be affected by the lockdown. We did not consider loss of production caused by any other countermeasures. The relationship between lockdown intensities and economic loss was assumed to be linear (ϕ = 0) for the main results. Also, non-linear relationships expressed as a power function were applied. This non-linearity came from the discussion in [19]. In this setting, mild countermeasures against infectious diseases such as teleworking could be taken without significant economic loss, but stronger measures such as the closure of companies to achieve stronger behavioral restraint requirements would result in greater economic loss. Simulations with values of one, two or three for ϕ were also performed for the case of the lockdown imposed equally to each age group.

In addition to analysis with 1.3 of basic reproduction number, R0, we performed sensitivity analysis varying the basic reproduction number. Also, we performed the same analysis with age group specific lockdown intensity, Lj, varying R0.

We estimated parameters, Lj and ts, to minimize the cumulative number of deaths. TL were calculated from Lj and E for each step. Ordinal differential equation was solved by Explicit Runge-Kutta method of order 5(4) [20] and optimization was done with differential evolution implemented in a Python package, Scipy version 1.5.3 [21, 22].

SEIR model scheme

Equations of our SEIR model in the present study are shown as

dSj,u(t)dt=λj(t)Sj,u(t)Vj,u(t)Sj,u(t), (2)
dEj,u(t)dt=λj(t)Sj,u(t)τEj,u(t)Vj,u(t)Ej,u(t), (3)
dIj,u(t)dt=τEj,u(t)γIj,u(t)Vj,u(t)Ij,u(t), (4)
dRj,u(t)dt=γ(1IFRj)Ij,u(t)Vj,u(t)Rj,u(t), (5)
dDj,u(t)dt=γIFRjIj,u(t)Vj,u(t)Dj,u(t), (6)
dSj,v(t)dt=(1VEλ)λj(t)Sj,v(t)+Vj,u(t)Sj,u(t), (7)
dEj,v(t)dt=(1VEλ)λj(t)Sj,v(t)τEj,v(t)+Vj,u(t)Ej,u(t), (8)
dIj,v(t)dt=τEj,v(t)γIj,v(t)+Vj,u(t)Ij,u(t), (9)
dRj,v(t)dt=γ(1(1VEd)IFRj)Ij,v(t)+Vj,u(t)Rj,u(t), (10)
dDj,v(t)dt=γ(1VEd)IFRjIj,v(t)+Vj,u(t)Dj,u(t), (11)

where

Vj,u(t)=Npj(t)Tvac1Nj,u(t), (12)

and semantics of them are depicted in Fig 1.

Fig 1. Schematic of SEIR model composed of vaccinated and non-vaccinated compartments.

Fig 1

Subscript j represents young, middle, or old age group. Black shaded box represents death status.

Our model consisted of contact matrix, infection fatality ratio (IFR) and vaccinated and unvaccinated compartments for simulating infection dynamics of age-stratified populations with vaccination. We refers Sj,u and Sj,v as unvaccinated and vaccinated susceptible populations of age group j. Exposed, infected and recovered populations are similarly defined. Vaccines were distributed at a rate of N/Tvac for the population and Npj/TvacNj,u for each compartment where N is total number of the population, Tvac is the whole interval of vaccination, and Nj,u is total number of unvaccinated population. Vaccine allocation percentage for age group j, pj is time-varying parameters taking between 0 to 1 determined by vaccine allocation strategies. For old-other strategies, a mean vaccine allocation percentage for old generation, po, takes 1 till the end of their vaccination and the others are 0. After that, mean vaccine allocation percentages for young, py, and middle generations, pm, take percentage of population among two to distribute vaccine according to population size until the whole population is vaccinated. Vaccine effect is assumed to be a leaky one, meaning that vaccinated populations were less likely, not completely, to be infected compared to unvaccinated individuals. Infected and recovered individuals also received vaccination in our model. There are three reasons for this. One reason is that insufficient immunity has been controversial now [23], and that vaccination would contribute to reduce reinfection. The third reason is that it is difficult for asymptomatic cases to be separated from susceptible ones without tests. Death cases are also assumed to be vaccinated in the model to carry out a predetermined vaccination plan.

Force of infection and basic reproduction number

Force of infection for age group j, λj, is an inflow rate from susceptible population to exposed population. Taking lockdown effect into account, force of infection for age group j is derived as

λj=uN(1θLj(t))kρjk(1θLk(t))(Ik(t)+Ik,v(t)), (13)

where u is a successful transmission rate given one contact, and ρjk is a contact rate for age group j with age group k.

The basic reproduction number was calculated from absolute of the dominant eigen value of the matrix M, which was the product of a matrix C and a diagonal matrix of which element was u/γ where 1/γ was infectiousness period. The matrix C represents contact matrix weighted by population size which elements were written as ρjk Nk. This derivation method of R0 was described in [24].

Parameter specification

Parameters used in this study are summarized in Table 1. Most parameters came from resources in Japan in order to perform simulation under the Japanese setting. We had to modify several original data to be compatible with our model, which were contact rates, IFR and production values.

Table 1. Summary of parameters used in the simulations.

Symbols Descriptions Values References
τ 1/ Latent period (/day). 1/3 [25]
γ 1/ Infectiousness period (/day). 1/5 [26]
u Transmission rate given one contact. 0.05882 when R0 = 1.5 Calculation
ρ jk Contact matrix for age group j with age group k . [[10.482, 1.567, 0.332], [7.250, 3.506, 0.879], [3.105, 1.789, 2.926]] [27]
IFR j Infection fatality ratio for age group i (%) [0.030, 0.295, 4.893] [28]
N j Population for age group j (×103) . [50557, 23987, 36155] [29]
[E(0), I(0), R(0)] Initial number for E, I and R compartments*. [9540, 18685, 358145] [30]
θ Lockdown efficiency. 0.75 Assumption
w j Production value for age group j (×103 yen) . [3742, 4474, 812] [31, 32]
VE λ Vaccine efficacy for transmission. 0.95 [33]
VE d Vaccine efficacy for death. 0.84 [34]

The order of values listed is young, middle and old age group.

* These values were assigned to each age group proportional to population size.

To truncate the original data to the values used in the model, we denote x5i,5j as contact rates of a person among 5i to 5(i+1) -1 age interval with a person among 5j to 5(j+1) -1 age interval and N5i represents population size for 5i to 5(i+1) -1 years old since original data had 5-year interval values. We combined rows for each age interval and took weighted summarization for columns by population size. For example, contact rate of young group with middle group, ρym, was calculated as

ρym=i=39N5ij=1012x5i,5ji=39N5i, (14)

where contact rates for young with middle age group were summed over from 50–54 to 60–64 age interval and were weighted by each age interval from 15–19 to 45–49 age interval. Similar calculation was done for other age group pairs, noting that we ignored population from 0 to 14 years old. The contact rates of the reference paper [27] did not have the ones of age more than 79 years old, so that we copied rows and columns of 75–79 years old diagonally. We multiplied 0.9 for these rows and columns since we considered older populations had lower contact rate than that of 75–79 years.

The reference of IFR [28] showed that the relationship between IFR and age was exponential. Since we were able to calculate infection fatality ratio at any age using this relationship, IFR of each age group was calculated as weighted means of IFR for each 5-age interval. For example, the equation for young age group was derived as

IFRy=i=39N5iIFR5i+2i=39N5i, (15)

where IFR5i+2 represents the infection fatality rate at age 5i +2, which is a median of each age interval. For old age group, more than 80 years old were grouped as one and we chose IFR at 85 years old for this group.

Production value was intended to reflect production values by workers. We obtained values of salary for each 5-age intervals, and weighted summaries by population size were used for production value for each age group, wj.

We set the initial number of each SEIR component as the status on 1st February 2021 in Japan. We set initial value for Ej as sum of newly reported cases during 29th to 31st January 2021 multiplied by a percentage of population size for age group j and for Ij and Rj as sum of ones during 23rd to 28th January 2021 and the cumulative number of cases till 22nd January 2021, respectively, multiplied by the same percentage. Actual values can be seen in Table 1.

Results

Fig 2 illustrates the relationship between economic loss and lockdown intensity and length values. x and y axis represent intensity and length of the lockdown and z axis represents the cumulative number of deaths at the end of the simulation. Optimization of parameters (TL, L and ts) for the lockdown imposing equally to each age group was done along each line drawn by constraint of predefined economic loss value, E. The start timing of the lockdown, ts, was estimated to be 0th day for almost all simulations. ts was estimated to be more than 0th day (sometimes around 70th day) when ϕ took a value of 0, R0 was higher, economic losses were lower, and the strategies were the middle first ones, the old first ones, or the equal strategy. In the case of a value of ϕ more than zero, ts was estimated to be 0th day for all cases. Then, we omitted the value of ts from the following figures.

Fig 2. Illustration of relationship between economic loss and lockdown intensity and length values.

Fig 2

x and y axis represent lockdown intensity and length values. z axis represents the cumulative number of deaths at the end of the simulations. Each line was drawn with the same volume of economic loss, E. Points show the minimum cumulative number of deaths for each line. Values at these points were used for the optimized parameters and shown in the following figures.

Fig 3 summarizes the cumulative number of deaths and infected population at the end of the simulations under 10 vaccine allocation strategies for each acceptable economic loss, together with the lockdown intensity and length giving optimal results (see S1 Table for detail). The lockdown was equally imposed to all generations, the basic reproduction number, R0, was set to be 1.3 and ϕ took zero. Overall, three young first strategies were the most effective in reducing the number of deaths and infections for most of the cases. The fourth effective strategy would be one that distributed vaccine equally to all age groups, especially in lower acceptable economic loss. The strong lockdown with short interval was preferable for young first strategies since young population had high contact rates. Restricting and vaccinating this population simultaneously leaded to lower reproduction number.

Fig 3. The optimized results and parameters for R0 = 1.3 and ϕ = 0 when the lockdown was imposed equally to each generation.

Fig 3

The optimized results of the cumulative number of deaths (A) and infected (B) populations for each economic loss. (C) and (D) represents the lockdown intensity and length, which value pattern produced the results of (A) and (B) for each economic loss. Although there are only eight lines visible in (A) and (B), three lines of young first vaccination strategies have overlain each other. The order of age groups on the label shows vaccine allocation strategies.

The cumulative numbers of the deaths for all strategies under 4 patterns of the basic reproduction number when ϕ took zero are shown in Fig 4. The best strategies were young first ones in terms of the cumulative number of deaths or infected population regardless of R0 except the strong lockdown situation. In addition, the strategy distributing vaccine equally to all age groups was the fourth effective strategy in most sizes of economic losses under 1.5 of R0. However, when R0 was more than around 1.5, in situations where the lockdown was mild and caused little economic loss, three old first strategies were more effective than those of vaccinating all generations equally in terms of deaths. When comparing strategies prioritizing vaccination to the old or middle age group, the old first strategies were more effective when the lockdown caused little economic loss, while the middle first strategies were more effective when there was much economic loss due to the lockdown. The differences in the effectiveness of the middle and old first strategies were more apparent for larger values of R0.

Fig 4. The cumulative number of deaths with R0 taking 1.3, 1.5, 1.7 and 1.9 and ϕ = 0 when the lockdown was imposed equally to each generation.

Fig 4

Each line shows vaccine allocation strategies. Three lines of young first vaccination strategies have overlain each other.

The heatmap of the best strategies in terms of the cumulative number of deaths among the old strategies showed that early vaccination for the young (specifically the young-old-middle strategy) was most effective in reducing the number of deaths when ϕ was zero (Fig 5). However, as ϕ increased, the old first strategies were best strategies in case of low R0 and higher acceptable economic losses. Particularly, for the case where R0 was small and the acceptable economic loss was large, the old first strategies was clearly best strategies among all when ϕ took three (S1 Fig).

Fig 5. Heatmap of the best strategies in terms of the cumulative number of deaths among all strategies varying ϕ, R0 and acceptable economic losses.

Fig 5

As Japan has already decided to vaccinate to the old age groups first, we compared three old first strategies in order to clarify which order of vaccination was better after the old age group was vaccinated. Fig 6 summarizes the best old first strategy among three strategies, old-middle-young, old-young-middle, and old-other strategies, varying ϕ and R0 (see S2 Table for detail). When R0 was below 1.4 and ϕ took zero, the old-young-middle strategy was most effective in reducing deaths under almost all the economic loss patterns, whereas under larger R0, the old-middle-young strategy started to excel greater than the other strategies for low acceptable economic loss. For the value of ϕ more than zero, the old-young-middle strategy was the best for the almost all the cases. Especially, if ϕ took three, the old-young-middle strategy was best for all the settings.

Fig 6. Heatmap of the best strategies in terms of the cumulative number of deaths among the old first strategies varying ϕ, R0 and acceptable economic losses.

Fig 6

We also performed simulations under settings of the lockdown being imposed with different intensities to each age group for 1.3 of R0 (S2 and S3 Figs) and varying R0 (S4 and S5 Figs) when ϕ took zero. Over all trends of the cumulative number of deaths and infected population were similar as when the lockdown was equally imposed. One exception was when R0 took 2.0 and economic loss was 0.5% and the best strategy was old-middle-young strategy (S5 Fig). To achieve optimal strategies, the strong lockdown to young and old age group was preferable compared to middle age group.

Discussion

We explored the better vaccine allocation and intensive countermeasure strategies to balance economic sustainability with infection control against COVID-19 in Japan. The young first strategies (specifically the young-old-middle strategy) were better than any other strategies in lower acceptable economic loss and moderate to higher R0 when a linear relationship between lockdown intensity and acceptable economic losses (ϕ = 0) was assumed (Fig 5). If we applied a non-linear relationship expressed as a power function, which implied a large potential for reducing contact without economic loss, the old first strategy (specifically the old-young-middle strategy) became the best when lower R0. These results were obtained because the spread of infection was suppressed only by lockdown, and as a result, the effect of early vaccination of the young on the prevention of the spread of infection was diminished, and instead the effect of early vaccination of the elderly on the reduction of mortality was greatly contributed. These results indicated a high potential of remote work when prioritizing vaccination for the old generation.

If we focused on the old first strategies, as the Japan government has decided to vaccinate the old populations first, the old-young-middle strategy was the best for almost all the cases for ϕ more than zero (Fig 6). These results came from the fact that young age group had the highest contact rates for all age groups [25] and was more likely to transmit infection so that vaccinating young populations at an early stage would prevent them from transmitting infection and enable population to reach herd immunity at the early stage, resulting in the containment of the epidemic and reduction of deaths. Also, the non-linear relationship would contribute to containments of the epidemics and the role of vaccination came to be a containment of the epidemic.

Our results implied that the best strategy minimizing deaths was changed according to the value of R0 and how countermeasures causing economical damage was imposed. R0 of COVID-19 was estimated as more than 2 at early stage of the epidemic [35, 36]. However, effective case tracing [26, 37] and much public awareness reduced transmissibility and some study handling with negative values of serial interval reported lower value of R0 [38]. Also, our usage of a lockdown does not include countermeasures without economical damage, which will lead to lower R0. However, a new SARS-CoV-2 variant, VOC 202012/01 was reported to be 43–90% higher transmissibility than preexisting variants [39, 40] and has been appeared also in Japan. It indicates higher R0 setting is better for our results. As shown in Fig 4, as R0 increased, number of deaths increased exponentially, so that strategies should be chosen by assuming the worst.

Since we used relative volume of population size and salary for each age group for calculation of economic loss, E, comparison with other metrics can be done. The annual GDP growth rates for 2019 and 2020 were 0.3% and -4.8%, respectively [16]. If we focus on the quarterly GDP growth in 2020, these values are -0.6%, -8.3%, 5.3% and 2.8% from the earliest to the latest. If this volume of decline is totally caused from countermeasures and contributes to reduce transmissibility, sufficient decline can be achieved. However, there are many measures to reduce transmissibility without economical damage so that raising each person’s awareness of infection control is important.

While our analysis assumed that the entire population would eventually be vaccinated in one year, this assumption would not be accurate in terms of vaccination rate and final percentage of vaccination. Also, vaccination efficacy for transmissibility and deaths were not accurately evaluated [34] and how long its immunity sustains and how protective for new strains it is remains unknown.

As for a lockdown, its intensity in the present study was assumed to be precisely controlled by policy makers but in practice the actual extent of the contact reduction may not be obvious until a lockdown is in practice. Although the one-time lockdown assumption was adopted in this study, this implementation should be caution in the real-world settings. The simple SEIR model study [19] showed constant strong lockdown strategy was not optimal if the vaccination was started at the end of the simulation. The gradual relaxation strategy was preferred, and this strategy was conducted in the UK and Israel during vaccination. For the lockdown with age-specific intensities, the results were not much changed from the lockdown with the same intensity to all age groups (S5 Fig). The one exceptional result in S5 Fig when R0 took 2.0 and economic loss was 0.5% indicated old-first strategy started to beat other strategies in case of higher R0 with weak lockdown.

There are several limitations to our study. First, although the results of this study relied highly on parameters, especially contact rates, the contact rates referred to in the present study were based on data from [27], which did not take into account behavioral changes brought about by the COVID-19 pandemic. Second, our analysis excluded children aged from 0 to 15 years old. Several studies suggested children were less likely to contribute to epidemics [25, 4042], the number of children cases has been increasing due to a new variant of SARS-CoV-2. Third, our model of economic loss considered only the impact of direct behavioral restraint due to the lockdown, and did not take into account the value that infectious disease victims were expected to produce in the future, which had been taken into account in several previous studies about economic losses by COVID-19 pandemic [18, 43]. Finally, since the calculations in this study were based on the population structure and contact rates in Japan, the results obtained in this study are not directly applicable to the situation of foreign countries.

Supporting information

S1 Fig. The cumulative number of deaths with R0 taking 1.3, 1.5, 1.7 and 1.9 and ϕ taking 1, 2, and 3 when the lockdown was imposed equally to each generation.

Each line shows vaccine allocation strategies. Three lines of young first vaccination strategies have overlain each other.

(TIF)

S2 Fig. The optimized results for R0 = 1.3 when the lockdown was imposed with different intensities to each age group.

The optimized results of the cumulative number of deaths and infected population for each economic loss is presented. Three lines of young first vaccination strategies have overlain each other. The order of age groups on the label shows vaccine allocation strategies.

(TIF)

S3 Fig. The optimized parameters for R0 = 1.3 when the lockdown was imposed with different intensities to each age group.

Each figure block contains lockdown intensities for young (blue), middle (yellow) and old (green) age group and lockdown length (red). It is noted that y axis represented lockdown intensity and lockdown length.

(TIF)

S4 Fig. The cumulative number of deaths with R0 taking 1.3, 1.5, 1.7 and 1.9, and ϕ = 0 when the lockdown was imposed with different intensities to each age group.

Each line shows vaccine allocation strategies. Three lines of young first vaccination strategies have overlain each other.

(TIF)

S5 Fig. Heatmap of the best strategy in terms of the cumulative number of deaths among all strategies varying R0 and acceptable economic losses when the lockdown was imposed with different intensities to each age group.

(TIF)

S1 Table. Numerical results for the beset strategy among all to minimize the cumulative number of deaths imposing same intensity of the lockdown to all age groups.

(DOCX)

S2 Table. Numerical results for the beset strategy among the three old first strategies to minimize the cumulative number of deaths imposing same intensity of the lockdown to all age groups.

(DOCX)

Acknowledgments

We thank for Yusuke Asai for valuable technical advice and useful discussions.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382: 727–733. doi: 10.1056/NEJMoa2001017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395: 565–574. doi: 10.1016/S0140-6736(20)30251-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard. [cited 1 Apr 2021]. Available: https://covid19.who.int/
  • 4.Tian H, Liu Y, Li Y, Wu C-H, Chen B, Kraemer MUG, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020;368: 638–642. doi: 10.1126/science.abb6105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Imperial College COVID-19 Response Team, Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584: 257–261. doi: 10.1038/s41586-020-2405-7 [DOI] [PubMed] [Google Scholar]
  • 6.Hyafil A, Moriña D. Analysis of the impact of lockdown on the reproduction number of the SARS-Cov-2 in Spain. Gaceta Sanitaria. 2020; S0213911120300984. doi: 10.1016/j.gaceta.2020.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Alfano V, Ercolano S. The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis. Appl Health Econ Health Policy. 2020;18: 509–517. doi: 10.1007/s40258-020-00596-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Caristia S, Ferranti M, Skrami E, Raffetti E, Pierannunzio D, Palladino R, et al. Effect of national and local lockdowns on the control of COVID-19 pandemic: a rapid review. E&P. 2020;44: 60–68. doi: 10.19191/EP20.5-6.S2.104 [DOI] [PubMed] [Google Scholar]
  • 9.Ambikapathy B, Krishnamurthy K. Mathematical Modelling to Assess the Impact of Lockdown on COVID-19 Transmission in India: Model Development and Validation. JMIR Public Health Surveill. 2020;6: e19368. doi: 10.2196/19368 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.You S, Wang H, Zhang M, Song H, Xu X, Lai Y. Assessment of monthly economic losses in Wuhan under the lockdown against COVID-19. Humanit Soc Sci Commun. 2020;7: 52. doi: 10.1057/s41599-020-00545-4 [DOI] [Google Scholar]
  • 11.Nurchis MC, Pascucci D, Sapienza M, Villani L, D’Ambrosio F, Castrini F, et al. Impact of the Burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and Productivity Loss. IJERPH. 2020;17: 4233. doi: 10.3390/ijerph17124233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mottaleb KA, Mainuddin M, Sonobe T. COVID-19 induced economic loss and ensuring food security for vulnerable groups: Policy implications from Bangladesh. Zereyesus Y, editor. PLoS ONE. 2020;15: e0240709. doi: 10.1371/journal.pone.0240709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hale T, Angrist N, Goldszmidt R, Kira B, Petherick A, Phillips T, et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav. 2021. [cited 29 Mar 2021]. doi: 10.1038/s41562-021-01079-8 [DOI] [PubMed] [Google Scholar]
  • 14.Tan-Torres Edejer T, Hanssen O, Mirelman A, Verboom P, Lolong G, Watson OJ, et al. Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries: a modelling study. The Lancet Global Health. 2020;8: e1372–e1379. doi: 10.1016/S2214-109X(20)30383-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.The Global Economic Outlook During the COVID-19 Pandemic: A Changed World. In: World Bank [Internet]. [cited 1 Apr 2021]. Available: https://www.worldbank.org/en/news/feature/2020/06/08/the-global-economic-outlook-during-the-covid-19-pandemic-a-changed-world
  • 16.Cabinet Office. System of National Accounts. [cited 1 Apr 2021]. Available: https://www.esri.cao.go.jp/jp/sna/menu.html
  • 17.Coronavirus (COVID-19) Vaccinations—Statistics and Research. In: Our World in Data [Internet]. [cited 1 Apr 2021]. Available: https://ourworldindata.org/covid-vaccinations
  • 18.Acemoglu D, Chernozhukov V, Werning I, Whinston M. Optimal Targeted Lockdowns in a Multi-Group SIR Model. Cambridge, MA: National Bureau of Economic Research; 2020May p. w27102. Report No.: w27102. doi: 10.3386/w27102 [DOI] [Google Scholar]
  • 19.Rowthorn R, Maciejowski J. A cost–benefit analysis of the COVID-19 disease. Oxford Review of Economic Policy. 2020;36: S38–S55. doi: 10.1093/oxrep/graa030 [DOI] [Google Scholar]
  • 20.Dormand JR, Prince PJ. A family of embedded Runge-Kutta formulae. Journal of Computational and Applied Mathematics. 1980;6: 19–26. doi: 10.1016/0771-050X(80)90013-3 [DOI] [Google Scholar]
  • 21.SciPy 1.0 Contributors, Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17: 261–272. doi: 10.1038/s41592-019-0686-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Storn R, Price K. Differential Evolution–A Simple and Efficient Heuristic for global Optimization over Continuous Spaces. Journal of Global Optimization. 1997;11: 341–359. doi: 10.1023/A:1008202821328 [DOI] [Google Scholar]
  • 23.Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. The Lancet Infectious Diseases. 2021;21: 52–58. doi: 10.1016/S1473-3099(20)30764-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Diekmann O, Heesterbeek JAP, Roberts MG. The construction of next-generation matrices for compartmental epidemic models. J R Soc Interface. 2010;7: 873–885. doi: 10.1098/rsif.2009.0386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.CMMID COVID-19 working group, Davies NG, Klepac P, Liu Y, Prem K, Jit M, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020;26: 1205–1211. doi: 10.1038/s41591-020-0962-9 [DOI] [PubMed] [Google Scholar]
  • 26.Ferretti L, Wymant C, Kendall M, Zhao L, Nurtay A, Abeler-Dörner L, et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science. 2020;368: eabb6936. doi: 10.1126/science.abb6936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using contact surveys and demographic data. Halloran B, editor. PLoS Comput Biol. 2017;13: e1005697. doi: 10.1371/journal.pcbi.1005697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020;35: 1123–1138. doi: 10.1007/s10654-020-00698-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ministry of Internal Affairs and Communications. Population Estimates, Monthly Report in September 1, 2020 (Final estimates), February 1, 2021 (Provisional estimates). [cited 3 Mar 2021]. Available: https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&toukei=00200524&tstat=000000090001&cycle=1&year=20210&month=11010302&tclass1=000001011678&tclass2val=0
  • 30.Ministry of Health, Labour and Welfare. Open data in “About Coronavirus Disease 2019(COVID-19).” [cited 3 Mar 2021]. Available: https://www.mhlw.go.jp/stf/covid-19/open-data.html
  • 31.Ministry of Health, Labour and Welfare. Basic Survey on Wage Structure. [cited 3 Mar 2021]. Available: https://www.e-stat.go.jp/stat-search/files?page=1&toukei=00450091&tstat=000001011429
  • 32.Ministry of Health, Labour and Welfare. Survey on Employment Trends. [cited 3 Mar 2021]. Available: https://www.e-stat.go.jp/stat-search/files?page=1&toukei=00450073&tstat=000001012468
  • 33.Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383: 2603–2615. doi: 10.1056/NEJMoa2034577 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021;384: 1412–1423. doi: 10.1056/NEJMoa2101765 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Alimohamadi Y, Taghdir M, Sepandi M. Estimate of the Basic Reproduction Number for COVID-19: A Systematic Review and Meta-analysis. J Prev Med Public Health. 2020;53: 151–157. doi: 10.3961/jpmph.20.076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. JCM. 2020;9: 967. doi: 10.3390/jcm9040967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kretzschmar ME, Rozhnova G, Bootsma MCJ, van Boven M, van de Wijgert JHHM, Bonten MJM. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study. The Lancet Public Health. 2020;5: e452–e459. doi: 10.1016/S2468-2667(20)30157-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bao C, Pan E, Ai J, Dai Q, Xu K, Shi N, et al. COVID‐19 outbreak following a single patient exposure at an entertainment site: An epidemiological study. Transbound Emerg Dis. 2020; tbed.13742. doi: 10.1111/tbed.13742 [DOI] [PubMed] [Google Scholar]
  • 39.Leung K, Shum MH, Leung GM, Lam TT, Wu JT. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Eurosurveillance. 2021;26. doi: 10.2807/1560-7917.ES.2020.26.1.2002106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021; eabg3055. doi: 10.1126/science.abg3055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Monod M, Blenkinsop A, Xi X, Hebert D, Bershan S, Tietze S, et al. Age groups that sustain resurging COVID-19 epidemics in the United States. Science. 2021; eabe8372. doi: 10.1126/science.abe8372 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Doyle T, Kendrick K, Troelstrup T, Gumke M, Edwards J, Chapman S, et al. COVID-19 in Primary and Secondary School Settings During the First Semester of School Reopening—Florida, August–December 2020. MMWR Morb Mortal Wkly Rep. 2021;70. doi: 10.15585/mmwr.mm7012e2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Alvarez FE, Argente D, Lippi F. A Simple Planning Problem for COVID-19 Lockdown. National Bureau of Economic Research; 2020Apr. Report No.: w26981. doi: 10.3386/w26981 [DOI] [Google Scholar]

Decision Letter 0

Martial L Ndeffo Mbah

19 May 2021

PONE-D-21-12208

Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan

PLOS ONE

Dear Dr. Kimura,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 03 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Martial L Ndeffo Mbah, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

  1. Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

  2. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

  3. If any authors received a salary from any of your funders, please state which authors and which funders.

  4. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper is on "Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan". There were several articles published on that topic this year, and I do not think that this paper enters the top 20%. There is nothing really new here. Here are some comments

1) (42) "COVID-19 has affected 42 tens of millions of people" it might depend on what "affect" means but if we include lockdowns for instance, it would be more "billions"

2) (58) the grammar "vaccination in healthcare workers" is odd, but I am not a native English spearker

3) (88) "lockdown was performed only once" is that a relevent assumption ? so far, many countries have faced second or third wave, so it would make sense to assume that multiple lockdown is possible. Furhermore I have major concern about the design of the lockdown : it is constant, over a given period of time, and uniform over the classes (same theta). Why ? In equation (1) the economic loss is linear... can't we assume that some people can work from home ? can't we assume that E is not linear in theta ? or N ? These assumptions are extremely strong, and not enough discuss. The problem is that all conclusions rely on those assumptions

4) SEIR model (105) is that relevant for a COVID-19 type of pandemic ? what about asymptomatic ? that was the main challenge at first, and a strong motivation for lockdowns early 2020

5) (128) again, things are uniform over classes... aren't there are more interactions within age classes ? Here having a similar theta is weird

Reviewer #2: Reviewer Report

(Recommendation)

I recommend the research article. However, it would be appropriate for the authors to consider some recommendations.

1. Summary of the investigation:

The article uses the SEIR model. Apply an optimization method with the differential evolution method and use a proven Python algorithm. The research question: What is the most appropriate vaccination strategy based on economic cost? and of course, it assumes other variables or parameters that the literature and evidence review suggests. In this context, it seeks to balance the economy and infection control in Japan.

One of the greatest strengths is in having a proven methodology that is better than other existing ones. But as a weakness is that no appendix shows how the theoretical-mathematical model derives, and secondly, to be able to replicate the results in Python. Of course, this situation does not affect the results.

The main result of the study is that the effective vaccination strategy that prioritizes the younger generation outperformed the other strategies in terms of deaths, explained by the contact rate and therefore the transmission.

2. Evidence and examples:

First, a review of the literature on the current situation of the Vaccine against the Pandemic would be important. It could expand the description of the state of the art of public health policies that have been carried out and compare not only at the level of Japan but at least at the Asian or the Asia Pacific and/or Global level.

Second, review of the empirical evidence that can be presented (Results) and compared (Discussion) in the present study. It is important to compare the results with others in the region, at the level of Asia, Asia-Pacific, at the level of developed countries or the world.

Reviewer #3: Please see an attachment file.

Please see an attachment file.

Please see an attachment file.

Please see an attachment file.

Please see an attachment file.

Please see an attachment file.

Please see an attachment file.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Tsuyoshi HONDOU

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer Report - recommendation.docx

Attachment

Submitted filename: Reviewers report (PLOS).pdf

PLoS One. 2021 Sep 2;16(9):e0257107. doi: 10.1371/journal.pone.0257107.r002

Author response to Decision Letter 0


6 Aug 2021

We are most grateful to you and the reviewers for the comments on our manuscript.

See the file uploaded to response to reviewers.

Attachment

Submitted filename: review_R1_26July2021.docx

Decision Letter 1

Martial L Ndeffo Mbah

24 Aug 2021

Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan

PONE-D-21-12208R1

Dear Dr. Kimura,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Martial L Ndeffo Mbah, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper has been substentialy improved. I still do no see real innovations in the paper (compared with several papers published recently on the same topic), but since the editor and the two other referees think that it is relevant that such a paper could be published in PLOS ONE, I will not go against it

Reviewer #2: The authors respond appropriately to the reviewers' suggestions.

The authors use and extend the SEIR model. They apply an optimization method with the differential evolution method and use a Python algorithm.

The authors manage to add the observations by making an article more suitable for publication according to the journal Plos-One.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Martial L Ndeffo Mbah

26 Aug 2021

PONE-D-21-12208R1

Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan

Dear Dr. Kimura:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Martial L Ndeffo Mbah

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. The cumulative number of deaths with R0 taking 1.3, 1.5, 1.7 and 1.9 and ϕ taking 1, 2, and 3 when the lockdown was imposed equally to each generation.

    Each line shows vaccine allocation strategies. Three lines of young first vaccination strategies have overlain each other.

    (TIF)

    S2 Fig. The optimized results for R0 = 1.3 when the lockdown was imposed with different intensities to each age group.

    The optimized results of the cumulative number of deaths and infected population for each economic loss is presented. Three lines of young first vaccination strategies have overlain each other. The order of age groups on the label shows vaccine allocation strategies.

    (TIF)

    S3 Fig. The optimized parameters for R0 = 1.3 when the lockdown was imposed with different intensities to each age group.

    Each figure block contains lockdown intensities for young (blue), middle (yellow) and old (green) age group and lockdown length (red). It is noted that y axis represented lockdown intensity and lockdown length.

    (TIF)

    S4 Fig. The cumulative number of deaths with R0 taking 1.3, 1.5, 1.7 and 1.9, and ϕ = 0 when the lockdown was imposed with different intensities to each age group.

    Each line shows vaccine allocation strategies. Three lines of young first vaccination strategies have overlain each other.

    (TIF)

    S5 Fig. Heatmap of the best strategy in terms of the cumulative number of deaths among all strategies varying R0 and acceptable economic losses when the lockdown was imposed with different intensities to each age group.

    (TIF)

    S1 Table. Numerical results for the beset strategy among all to minimize the cumulative number of deaths imposing same intensity of the lockdown to all age groups.

    (DOCX)

    S2 Table. Numerical results for the beset strategy among the three old first strategies to minimize the cumulative number of deaths imposing same intensity of the lockdown to all age groups.

    (DOCX)

    Attachment

    Submitted filename: Reviewer Report - recommendation.docx

    Attachment

    Submitted filename: Reviewers report (PLOS).pdf

    Attachment

    Submitted filename: review_R1_26July2021.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES